- 2 hrs ago Tamil Actress Ramya Pandian Graces Cook With Comali Show In A Blue Khadi Linen Sari
- 2 hrs ago Shraddha Kapoor And Rakul Preet Singh's Street-Style Looks Are Something To Look Forward To
- 3 hrs ago Instagram Beauty Looks Of The Week: Deepika Padukone, Priyanka Chopra, Sonam Kapoor And More
- 3 hrs ago Severe Acute Respiratory Syndrome (SARS): Causes, Symptoms, Risk factors, Treatment And Prevention
- Movies Dance Plus 5: Shah Rukh Khan In Awe Of 'Fauji' Bhim Bahadur’s Performance
- Technology Airtel Vs Reliance Jio Vs Vodafone: Best Prepaid Plans That Offers 3GB Data
- Sports Pakistan trump Bangladesh to bag T20I series
- News Mamata tweets, 'couldn't recognise Omar Abdullah'; his bearded photo goes viral
- Travel 10 Most Popular Historical Places And Sites In Karnataka
- Automobiles TVS iQube Electric Scooter Launched In India: Prices Start At Rs 1.15 Lakh
- Finance Top 10 Recurring Deposits with Higher Interest Rates
- Education IIM Bangalore Women In Leadership Course Tanmatra
Long-term, high-dose supplementation of vitamins B6 and B12 may be associated with a two to four-fold increased risk of lung cancer in men, a study has warned. Vitamin B intake has been long touted by the vitamin industry for increasing energy and improving metabolism, researchers from Ohio State University in the US said.
They found that the lung cancer risk was further elevated in male smokers taking more than 20 milligramme of vitamin B6 or 55 microgrammess of B12 a day for 10 years. Male smokers taking B6 at this dose were three times more likely to develop lung cancer.
Those taking B12 at such doses were about four times more likely to develop the disease compared to non-users, researchers said. They analysed data from more than 77,000 patients in the Vitamins And Lifestyle (VITAL) cohort study, a long-term prospective observational study designed to evaluate vitamin and other mineral supplements in relation to cancer risk.
All participants, aged between 50 and 76 years, were recruited between the years 2000 and 2002. Researchers used statistical techniques to adjust for numerous factors including: personal smoking history, age, race, personal history of cancer or chronic lung disease, family history of lung cancer and use of anti-inflammatory drugs.
"This sets all of these other influencing factors as equal, so we are left with a less confounded effect of long- term B6 and B12 super-supplementation," said Theodore Brasky from Ohio State University. The study was published in the Journal of Clinical Oncology.